Cost Assistance and Medication Access
Co-Pay Assistance Program
Most eligible patients pay as little as a $0 co-pay for each prescription.
This program is only valid for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication. The program is only valid for the cost of Orenitram and not applicable to any related supplies or other medical expenses associated with administering the product.
90-Day Trial Program
The 90-Day Trial Program allows you to assess how well your eligible* patients tolerate Orenitram at no cost for up to 90 days. See if they’re eligible to enroll in the program.View Program Details >
Access and Financial Assistance
Helping Patients Determine if They Qualify for United Therapeutics Patient Assistance Programs
ASSIST, the Access Solutions and Support Team, is committed to helping eligible patients:
- Access their prescribed therapies
- Navigate insurance coverage
- Find information on financial assistance and contracted pharmacies
ASSIST Offers Support During the Referral Process
Through ASSIST, the Orenitram Referral Portal allows you to track the status of prescriptions for your patients who have been prescribed Orenitram. Once you prescribe and submit the initial Referral Form, ASSIST will:
- Obtain any additional information needed from your patients
- Arrange for a Specialty Pharmacy to provide home medication delivery upon approval
- Discuss financial assistance options that may be available for patients who qualify
For more information, reach out to an ASSIST advisor at 1-877-UNITHER (1-877-864-84371-877-864-8437), Monday through Friday, 8:30 AM to 7:00 PM ET.
Additional Support Resources
Specialty Pharmacy Support
Read about how Specialty Pharmacies may help your patients access Orenitram, schedule nurse visits, and much more.
Discover how a United Therapeutics Virtual Patient Educator may help your patients get started on Orenitram.
Video and Resource Library
To access helpful videos, downloadable resources for patients, and recent publications, visit Video and Resource Library.